|
IKZF4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.39889999584142E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.00709995898285E-09 |
| Normal-vs-Stage2 |
8.903000E-03 |
| Normal-vs-Stage3 |
2.393200E-04 |
| Normal-vs-Stage4 |
8.08930000000263E-05 |
| Stage1-vs-Stage2 |
4.092000E-01 |
| Stage1-vs-Stage3 |
1.123780E-01 |
| Stage1-vs-Stage4 |
7.053000E-01 |
| Stage2-vs-Stage3 |
7.765400E-01 |
| Stage2-vs-Stage4 |
6.677800E-01 |
| Stage3-vs-Stage4 |
3.725600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.62599994474522E-09 |
| Normal-vs-AfricanAmerican |
1.524770E-03 |
| Normal-vs-Asian |
3.52230000000286E-06 |
| Caucasian-vs-AfricanAmerican |
4.092200E-01 |
| Caucasian-vs-Asian |
5.788200E-01 |
| AfricanAmerican-vs-Asian |
6.904200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.02430000004095E-06 |
| Normal-vs-Female |
3.41880002086015E-09 |
| Male-vs-Female |
6.978800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.79049999774017E-08 |
| Normal-vs-Age(41-60Yrs) |
3.11829999599667E-08 |
| Normal-vs-Age(61-80Yrs) |
7.767700E-04 |
| Normal-vs-Age(81-100Yrs) |
9.535000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.311800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.137800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.890000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.086400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.449700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.922960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.934400E-02 |
| Classical-VS-Follicular |
1.760270E-02 |
| Classical-VS-Other |
5.627200E-01 |
| Classical-VS-Normal |
1.18559606576696E-11 |
| Tall-VS-Follicular |
9.491800E-01 |
| Tall-VS-Other |
6.409800E-01 |
| Tall-VS-Normal |
4.123900E-02 |
| Follicular-VS-Other |
7.481800E-01 |
| Follicular-VS-Normal |
2.168300E-02 |
| Other-VS-Normal |
2.145000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.14290000031004E-07 |
| Normal-vs-N1 |
1.640980E-04 |
| N0-vs-N1 |
8.771600E-01 |
|
|
